Clinical Trials Browser

Breast Cancer Early Stage Breast Cancer (Stage 1-3) × 1 year × Clear all

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT06917313 2026-02-10

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Phase 2 Recruiting

92 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT07317778 2026-01-05

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Phase 2 Not yet recruiting

249 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT06885671 2025-11-17

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

Phase NA Not yet recruiting

60 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT07153757 2025-09-04

DESCENT

Phase 3 Not yet recruiting

2,934 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT06765707 2025-07-24

SyMPTOM

Phase NA Enrolling by invitation

225 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT06890221 2025-03-26

IPENIPA

Phase NA Recruiting

114 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT06807749 2025-03-24

PERSEVEREX

Not yet recruiting

800 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Clinical Trials

HER2BREASTDX

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

DESCENT

SyMPTOM

IPENIPA

PERSEVEREX